Evidence map›Paper›PMID 36999514›Full record

ArticleAging cell2023

Age-dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution.

Jennifer Adjei-Mosi, Qing Sun, Steven Blake Smithson, Gavyn Lee Shealy, Krupa Dhruvitha Amerineni, Zerong Liang, Hanqing Chen, Mei Wang, Qinggong Ping, Jingyan Han and 4 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Periodontitis and MASLD: a narrative review of the direct oral-hepatic pathway.Frontiers in cellular and infection microbiology · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Involvement of SIRT1-mediated aging in liver diseases.Frontiers in cell and developmental biology · 2025
    Review
  18. Article
  19. Involvement of role of HMGB1-NLRP3 pathway in systemic disorders.Frontiers in cell and developmental biology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Jennifer Adjei-MosiBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Qing SunBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Steven Blake SmithsonBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.ORCID 0000-0003-0229-9360
Gavyn Lee ShealyBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Krupa Dhruvitha AmerineniBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Zerong LiangBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Hanqing ChenBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Mei WangBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Qinggong PingBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Jingyan HanBoston University School of Medicine, Boston, Massachusetts, USA.
Masahiro MoritaBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Amrita KamatBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Nicolas MusiBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.
Mengwei ZangBarshop Institute for Longevity and Aging Studies, Center for Healthy Aging, San Antonio, Texas, USA.ORCID 0000-0002-2502-2586
The University of Texas Health Science Center at San Antonio · USLongevity Biotech (United States) · USBoston University · US

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI PETER J HORNSBY · 1995 to 2026
$30.6M
South Texas Medical Scientist Training Program (STX-MSTP)T32GM145432 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jose E Cavazos, Ratna K Vadlamudi · 2023 to 2026
$2.3M
Retinoic Acid Receptor, Lipid Metabolism, and Fatty Liver DiseaseR01DK100603 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZANG, MENGWEI · 2015 to 2018
$1.5M
Hepatokine Control of Metabolic Crosstalk and Insulin ResistanceR01DK121527 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZANG, MENGWEI · 2019 to 2020
$612k
Alcohol-induced dysregulation of thiol homeostasis and endothelial functionR21AA026922 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAN, JINGYAN, ZANG, MENGWEI · 2019 to 2020
$439k
NIAAA NIH HHS R21 AA026922NIA NIH HHS P30 AG013319NIDDK NIH HHS R01 DK100603NIDDK NIH HHS R01 DK121527NIGMS NIH HHS T32 GM145432
6 · The paper itself

Abstract

Our studies indicate that the longevity factor SIRT1 is implicated in metabolic disease; however, whether and how hepatocyte-specific SIRT1 signaling is involved in liver fibrosis remains undefined. We characterized a functional link of age-mediated defects in SIRT1 to the NLRP3 inflammasome during age-related liver fibrosis. In multiple experimental murine models of liver fibrosis, we compared the development of liver fibrosis in young and old mice, as well as in liver-specific SIRT1 knockout (SIRT1 LKO) mice and wild-type (WT) mice. Liver injury, fibrosis, and inflammation were assessed histologically and quantified by real-time PCR analysis. In a model of hepatotoxin-induced liver fibrosis, old mice displayed more severe and persistent liver fibrosis than young mice during liver injury and after injury cessation, as characterized by inhibition of SIRT1, induction of NLRP3, infiltration of macrophages and neutrophils, activation of hepatic stellate cells (HSCs), and excessive deposition and remodeling of the extracellular matrix. Mechanistically, deletion of SIRT1 in hepatocytes resulted in NLRP3 and IL-1β induction, pro-inflammatory response, and severe liver fibrosis in young mice, mimicking the ability of aging to impair the resolution of established fibrosis. In an aging mouse model, chronic-plus-binge alcohol feeding-induced liver fibrosis was attenuated by treatment with MCC950, a selective NLRP3 inhibitor. NLRP3 inhibition ameliorated alcoholic liver fibrosis in old mice by repressing inflammation and reducing hepatocyte-derived danger signaling-ASK1 and HMGB1. In conclusion, age-dependent SIRT1 defects lead to NLRP3 activation and inflammation, which in turn impairs the capacity to resolve fibrosis during aging.

Indexed as

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAnimalsFibrosisInflammationLiver CirrhosisMiceMice, KnockoutSirtuin 1InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseSirt1 protein, mouseSirtuin 1agingalcohol-associated liver diseasehepatic stellate cells (HSCs)hepatocyte-specific SIRT1 knockoutliver fibrosisMCC950NLRP3 inflammasome

Identifiers

PMID36999514
PMCPMC10186605
OpenAlexW4362471217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.